Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy

E-ISSN： 1522-2594|79|2|1010-1019

ISSN： 0740-3194

Source： MAGNETIC RESONANCE IN MEDICINE, Vol.79, Iss.2, 2018-02, pp. : 1010-1019

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathogen-Related Signal Transduction Pathways of Dendritic Cells: Perspectives for Cancer Immunotherapy

Current Signal Transduction Therapy, Vol. 3, Iss. 2, 2008-05 ,pp. : 133-137

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell Immunotherapy for Melanoma

Reviews on Recent Clinical Trials, Vol. 1, Iss. 2, 2006-05 ,pp. : 87-102

Bentham Science Publishers

Access to resources Recommend Favorite

On target: Genetically modified cells show promise in targeted immunotherapy for advanced blood cancers

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 929-930

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dendritic Cell Immunotherapy for Malignant Gliomas

Reviews on Recent Clinical Trials, Vol. 3, Iss. 1, 2008-01 ,pp. : 10-21

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of Pulmonary Dendritic Cells and Th2-Type Inflammatory Responses on Instillation of Engineered, Environmental Diesel Emission Source or Ambient Air Pollutant Particles in vivo

Journal of Innate Immunity, Vol. 3, Iss. 2, 2010-11 ,pp. : 150-166

Karger

Access to resources Recommend Favorite